Menu

27th Annual
San Diego Heart Failure Symposium

Advances in the Recognition & Treatment of Heart Failure
July 9 & 10, 2021

PROGRAM- Subject to Change
Friday, July 9, 2021

10:00

Introduction to the 27th Annual Symposium: Heart Failure in 2022
Where Do We Stand, Where Are We Going?

Barry Greenberg, MD

SESSION I - Case-Based Device Therapy for Heart Failure
10:15 - Ulrika Birgersdotter-Green, MD (Moderator)

10:15

Case 1. Left Ventricular Assist Device - Rise of the Machine
   Kimberly Hong, MD (Presenter)
Case 2. Cardiac Resynchronization Therapy - Beating N'Sync
   Douglas Darden, MD (Presenter)
Case 3. Remote Hemodynamic Monitoring - The Eye in the Sky
   Nitin Kabra, MD (Presenter)
Panel Discussion
   Drs. Eric Adler, Gordon Ho and Howie Tran (Discussants)

Session II - Update on Risk Factors and Prevention
11:15 - Pam Taub, MD (Moderator)

11:15-11:35

FEATURED LECTURE
Race, Ethnicity and CV Risk

Cheryl Anderson, MD, PhD

11:35-11:50

Management of Hypertension
Chris Mende, MD

11:50-12:05

New Therapies for Treating Hyperlipidemia
Pam Taub, MD

12:05-12:20

Diabetic Therapies That Reduce CV Risk
Jia Shen, MD

12:20-12:40

Panel Discussion
Pam Taub (Moderator)
Drs. Anderson, Mende, and Shen (Discussants)

12:40-1:00

Break/Visit Virtual Exhibit Hall

Session III - Supported CE Seminar

1:00-2:00

Pulmonary Arterial Hypertension and Post-Capillary Pulmonary Hypertension Related to Left Heart Disease
(with live Q&A)
Barry Greenberg, MD
Supported by an educational grant from Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson

CE credit for this session provided by AKH Inc., Advancing Knowledge in Healthcare
See Accreditation page for details.

2:00-2:20

Break/Visit Virtual Exhibit Hall

Session IV - Decompensated HF: Managing the Patient During Hospitalization and Post-Discharge
2:20pm - Barry Greenberg, MD (Moderator)

2:20-2:40

FEATURED LECTURE
Cardiac Consequences of COVID-19 Infection

Enrico Ammirati, MD, PhD

2:40-2:55

Expanding Use of ARNI’s to Improve Outcomes in HF Patients
Scott Solomon, M.D

2:55-3:10

Biomarkers to Assess Efficacy of Treatment and Residual Risk
James L. Januzzi, MD

3:10-3:25

The Cardiorenal Syndrome: Impact on Therapy and How to Manage
Nicholas Wettersten, MD

3:25-3:40

Out-Patient Monitoring to Reduce Readmissions
Howie Tran, MD

3:40-3:55

Preventing Sudden Death: Role of Wearable and Implanted Devices
Ulrika Birgersdotter-Green, MD

3:55-4:15

Panel Discussion and Audience Q/A
Barry Greenberg MD (Moderator)
Drs. Solomon, Januzzi, Wettersten, Tran and Julia McCain PA (Panelists)

4:20

Product Theater - Non-CME
XARELTO® 2.5 MG Vascular Dose: Reduction in the Risk of Major Cardiovascular Events in Patients With Chronic CAD or PAD
Dr. Arnold Seto, MD, MPA
Supported by: Janssen


Saturday, July 10

8:10

Welcome to Day 2 - Recap of Day 1 Highlights
Barry Greenberg, MD

Session V - HFpEF, Hypertrophic Cardiomyopathy and Infiltrative Diseases
8:20am - Kimberly Hong, MD (Moderator)

8:25-8:55

7th Annual Stanley Lloyd, MD Lecture
Recognizing and Treating HFpEF
Carolyn Lam, MD, PhD

8:55-9:10

Management of HCM
Jorge Silva Enciso, MD

9:10-9:25

The HCM Society: It Takes a Village
Lisa Salberg

9:25-9:45

Diagnosis, Differentiation and Treatment of Amyloid Disease
Marcus Anthony Urey, MD

9:45-10:00

HFmrEF: Tending To the Lost Child
Barry Greenberg, MD

10:00-10:20

Panel Discussion and Audience Q/A
Dr. Hong MD (Moderator)
Drs. Lam, Silva Enciso, Urey, Julia McCain, PA and Lisa Salberg (Panelists)

10:30-11:30

Product Theater - Non-CME
Selecting a Treatment for the Polyneuropathy of hATTR Amyloidosis in Adults
Barry Trachtenberg, MD
Supported by: Alnylam

11:30-11:45

Visit Virtual Exhibit Hall

Session VI - Optimizing the Medical Management of Patients with Heart Failure
11:45am - Barry Greenberg, MD (Moderator)

11:45-12:00

Complementary and Alternative Medicines: What Should We Be
Telling Our Patients?
Sheryl Chow, PharmD

12:00-12:15

SGLT2 Inhibition: Who, When and Why
Javed Butler, MD

12:15-12:30

Optimizing RAAS Inhibition by Controlling Hyperkalemia
Uri Elkayam, MD

12:30-12:45

New Treatments: Vericiguat and Omecamtiv Micarbil
Gregg Fonarow, MD

12:45-1:00

Advances in Gene and Cell Therapies
Barry Greenberg, MD

1:00-1:15

FEATURED LECTURE
Overcoming Disparities in Health:
Providing Optimal Care to All
Clyde Yancy, MD

1:15-1:35

Case Presentation/Audience Q&A
Barry Greenberg, MD (Moderator)
Drs. Butler, Elkayam, Fonarow and Yancy, and Sheryl Chow, Pharm D (Panelists)

1:45-2:45

Product Theater - Non-CME
Use of Dapagliflozin in Patients with HFrEF, Results of the Landmark DAPA-HF Clinical Trial
Warren Fegenbush, PharmD, BCPS
Supported by: AstraZeneca

2:45-3:00

Visit Virtual Exhibit Hall

Session VII - Advanced Heart Failure and Devices
3:00pm - Eric Adler, MD (Moderator)

3:00-3:15

Advances in Treatment with Mechanical Circulatory Support
Mandeep Mehra, MD

3:15-3:30

Percutaneous Mechanical Circulatory Support to Stabilize Patients
Eric Adler, MD

3:30-3:45

Managing Atrial Fibrillation: Rate Vs Rhythm Control, OAC vs
Device to Prevent Stroke
Jeanne Poole, MD

3:45-4:00

Catheter Based Management of Valvular Heart Disease
Ryan Reeves, MD

4:00-4:15

Managing Pulmonary Arterial Hypertension (PAH)
Demos Papamatheakis, MD

4:15-4:35

Panel Discussion and Audience Q/A
Eric Adler, MD (Moderator) – Drs. Mehra, Poole and Papamatheakis (Panelists)

4:35

Adjourn Until the 28th Annual San Diego Heart Failure Symposium